REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. focuses on the research, development, production and sales of peptides, biological products and chemicals. The company was founded in 2009 and is headquartered in Lianyungang City, China.

Headquarters
Room 1201, Block E, Science and Technology Park, Hangzhou Normal University, No. 1378, Wenyi West Road, Yuhang District, Hangzhou, Zhejiang Province
Hangzhou; Zhejiang; Postal Code: 311121

Contact Details: Purchase the Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. report to view the information.

Website: http://www.sinopep.com.cn

Basic Information
Total Employees:
Purchase the Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
April 03, 2009
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
9.38%
Purchase this report to view the information.
6.29%
Purchase this report to view the information.
6.29%
Purchase this report to view the information.
4.84%
Purchase this report to view the information.
4.46%
Subsidiaries
Hangzhou Aosino Biotechnology Co., Ltd.
100%
Hangzhou Aosino Pharmaceutical Technology Co., Ltd.
100%
Hangzhou Novo Equity Investment Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
76.51%▲
Total operating revenue
76.17%▲
Operating profit (EBIT)
221.66%▲
Net Profit (Loss) for the Period
288.2%▲
Total assets
52.5%▲
Total equity
32.91%▲
Operating Profit Margin (ROS)
14.04%▲
Net Profit Margin
15.28%▲
Return on Equity (ROE)
8.74%▲
Debt to Equity Ratio
22.12%▲
Quick Ratio
0.12%▲
Cash Ratio
0.05%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Liuzhou Liangmianzhen Co.,Ltd.
 
Hunan Hansen Pharmaceutical Co., Ltd.
Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. (三生国健药业(上海)股份有限公司)
 
Qianjiang Yongan Pharmaceutical Co.,Ltd.
Chengdu Huasun Technology Group Inc., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo